Chronic Myeloid Leukemia

Common Name(s)

Chronic Myeloid Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myeloid Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myeloid Leukemia" returned 1217 free, full-text research articles on human participants. First 3 results:

[β-arrestin1 promotes chronic myeloid leukemia cell proliferation by activating JNK signaling pathway].
 

Author(s): Hui Chen, Kang Li, Yi Wang, Zhenglan Tan, Lin Zou

Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2015 May;35(5):677-81.

 

To investigate the signaling pathways involved in β-arrestin1-induced proliferation of K562 cells.

Last Updated: 28 May 2015

Go To URL
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina.
 

Author(s): Jianxiang Wang, Zhi-Xiang Shen, Giuseppe Saglio, Jie Jin, He Huang, Yu Hu, Xin Du, Jianyong Li, Fanyi Meng, Huanling Zhu, Jianda Hu, Jianmin Wang, Ming Hou, Sabine Hertle, Hans D Menssen, Christine-Elke Ortmann, Catherine Tribouley, Ye Yuan, Michele Baccarani, Xiaojun Huang

Journal: Blood. 2015 Apr;125(18):2771-8.

 

Treatment with a tyrosine kinase inhibitor (TKI) targeting BCR-ABL1 is currently the standard of care for patients with chronic myeloid leukemia (CML) in chronic phase (CML-CP). In this study, we present results of the ENESTchina (Evaluating Nilotinib Efficacy and Safety in Clinical ...

Last Updated: 1 May 2015

Go To URL
Intracerebral Granulocytic Sarcoma in recurrence of Chronic Myeloid Leukemia.
 

Author(s): Angelo Borsarelli Carvalho Brito, Fabiano Reis, Ana Laura Gatti Palma, Carmen Silvia Passos Lima

Journal: Arq Neuropsiquiatr. 2015 Jan;73(1):68.

 

Last Updated: 22 Jan 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myeloid Leukemia" returned 144 free, full-text review articles on human participants. First 3 results:

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.
 

Author(s): N C P Cross, H E White, D Colomer, H Ehrencrona, L Foroni, E Gottardi, T Lange, T Lion, K Machova Polakova, S Dulucq, G Martinelli, E Oppliger Leibundgut, N Pallisgaard, G Barbany, T Sacha, R Talmaci, B Izzo, G Saglio, F Pane, M C Müller, A Hochhaus

Journal: Leukemia. 2015 May;29(5):999-1003.

 

Treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors has advanced to a stage where many patients achieve very low or undetectable levels of disease. Remarkably, some of these patients remain in sustained remission when treatment is withdrawn, suggesting that ...

Last Updated: 7 May 2015

Go To URL
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
 

Author(s): Bing Li, Robert Peter Gale, Zhijian Xiao

Journal:

 

According to the 2008 World Health Organization classification, chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia are rare diseases. The remarkable progress in our understanding of the molecular genetics of myeloproliferative neoplasms ...

Last Updated: 18 Dec 2014

Go To URL
[Bone marrow microenvironment in chronic myeloid leukemia: implications for disease physiopathology and response to treatment].
 

Author(s): José Alejandro Aristizábal, Mauricio Chandia, María Consuelo Del Cañizo, Fermín Sánchez-Guijo

Journal: Rev Med Chil. 2014 May;142(5):599-605.

 

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm related to the presence of the BCR-ABL1 fusion gene, linked to t (9;22) (q34;q11). It is originated from an abnormal hematopoietic stem cell, which is characterized as its normal counterparts by long-term self-renewal ...

Last Updated: 27 Nov 2014

Go To URL
 
 
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
 

Status: Recruiting

Condition Summary: Chronic Phase Philadelphia Positive; BCR-ABL Positive; Chronic Myeloid Leukaemia

 

Last Updated: 22 Feb 2015

Go to URL
Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia
 

Status: Recruiting

Condition Summary: Chronic Myeloid Leukemia

 

Last Updated: 23 Nov 2014

Go to URL
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
 

Status: Recruiting

Condition Summary: Chronic Myeloid Leukemia

 

Last Updated: 26 May 2015

Go to URL